Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Centuri Holdings	CTRI	31. jan 2025	22.28	-1.72
Centurion Acquisition	ALFUU	31. jan 2025	10.24	0.00
Century Aluminium	CENX	31. jan 2025	18.28	+0.55
Century Casinos	CNTY	31. jan 2025	3.14	+2.28
Century Communities	CCS	31. jan 2025	76.38	-2.33
Century Therapeutics	IPSC	31. jan 2025	0.82	-3.45
Ceragon Networks	CRNT	31. jan 2025	4.61	+0.22
Cerence	CRNC	31. jan 2025	12.46	-7.98
CeriBell	CBLL	31. jan 2025	23.01	-3.32
CERo Therapeutics	CERO	31. jan 2025	2.14	+7.54
Certara	CERT	31. jan 2025	14.23	+1.64
Cerus	CERS	31. jan 2025	1.87	-5.56
CervoMed	CRVO	31. jan 2025	2.26	+0.44
CEVA	CEVA	31. jan 2025	32.21	+0.25
CF Bankshares	CFBK	31. jan 2025	24.44	-1.97
CF Industries	CF	31. jan 2025	92.21	+0.01
CFSB Bancorp	CFSB	31. jan 2025	7.70	-0.65
CG Oncology	CGON	31. jan 2025	30.07	-0.27
CGI	GIB	31. jan 2025	117.82	-1.00
Chain Bridge Bancorp	CBNA	31. jan 2025	24.60	-1.24
Champion Homes	SKY	31. jan 2025	92.33	+0.80
Champions Oncology	CSBR	31. jan 2025	10.99	+2.71
ChampionX	CHX	31. jan 2025	28.64	-1.95
Channel Therapeutics	CHRO	31. jan 2025	2.34	-4.10
Chanson International	CHSN	31. jan 2025	0.54	-2.66
ChargePoint	CHPT	31. jan 2025	0.96	-4.73
Charles & Colvard	CTHR	31. jan 2025	1.44	-5.26
Charles River Laboratories International	CRL	31. jan 2025	164.76	-0.49
Charles Schwab	SCHW	31. jan 2025	82.72	-1.05
Charlton Aria Acquisition	CHAR	31. jan 2025	10.02	0.00

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.